Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
NMOSD and MOGAD: Updates on diagnostic criteria
1Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), service sclérose en plaques, pathologie de la myeline et neuro-inflammation, hôpital neurologique Pierre-Wertheimer, hospices civils de Lyon, Lyon, France.
None:
Recently, diagnostic criteria for demyelinating diseases, including multiple sclerosis, have been updated with a focus on imaging and fluid markers. The upcoming criteria for neuromyelitis optica (NMO) introduce several clinico-radiological updates, and highlight the need for accurate determination of AQP4-IgG status. Furthermore, seronegative NMO is now considered a syndrome distinct from AQP4-IgG disease. The MOG-antibody associated disease (MOGAD) criteria have been validated in different populations, and a clear role for case-by-case expert review has emerged in light of some limitations to clinical application of the criteria. The impact and the limitations of these criteria will be discussed in this mini-review.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Methods of Documentation II: POMR
Mitral Stenosis II: Clinical features and Diagnostic Tests
Formulating and Validating Nursing Diagnosis II
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Oppositional Defiant Disorder
Diagnostic Criteria and...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

